GO:0097159 | organic cyclic compound binding | 36.36% (20/55) | 1.42 | 1.8e-05 | 0.000759 |
GO:1901363 | heterocyclic compound binding | 36.36% (20/55) | 1.42 | 1.8e-05 | 0.000759 |
GO:0046483 | heterocycle metabolic process | 21.82% (12/55) | 2.05 | 2.3e-05 | 0.00081 |
GO:0006725 | cellular aromatic compound metabolic process | 21.82% (12/55) | 2.02 | 2.7e-05 | 0.000814 |
GO:1901360 | organic cyclic compound metabolic process | 21.82% (12/55) | 1.98 | 3.6e-05 | 0.000971 |
GO:1901293 | nucleoside phosphate biosynthetic process | 7.27% (4/55) | 4.72 | 1.4e-05 | 0.001028 |
GO:0009165 | nucleotide biosynthetic process | 7.27% (4/55) | 4.72 | 1.4e-05 | 0.001028 |
GO:0009117 | nucleotide metabolic process | 7.27% (4/55) | 4.22 | 5.8e-05 | 0.001394 |
GO:0006753 | nucleoside phosphate metabolic process | 7.27% (4/55) | 4.16 | 7.1e-05 | 0.001517 |
GO:0005488 | binding | 43.64% (24/55) | 1.06 | 0.000126 | 0.001935 |
GO:0003723 | RNA binding | 9.09% (5/55) | 3.36 | 0.000118 | 0.001954 |
GO:0034641 | cellular nitrogen compound metabolic process | 21.82% (12/55) | 1.81 | 0.00011 | 0.00197 |
GO:0016879 | ligase activity, forming carbon-nitrogen bonds | 5.45% (3/55) | 5.0 | 0.000104 | 0.002032 |
GO:0006139 | nucleobase-containing compound metabolic process | 21.82% (12/55) | 2.16 | 1e-05 | 0.002254 |
GO:0090407 | organophosphate biosynthetic process | 7.27% (4/55) | 3.77 | 0.0002 | 0.002863 |
GO:0003676 | nucleic acid binding | 20.0% (11/55) | 1.81 | 0.000222 | 0.00298 |
GO:0016874 | ligase activity | 7.27% (4/55) | 3.54 | 0.000377 | 0.004504 |
GO:0016741 | transferase activity, transferring one-carbon groups | 7.27% (4/55) | 3.54 | 0.000377 | 0.004504 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 7.27% (4/55) | 3.45 | 0.000472 | 0.005345 |
GO:0034660 | ncRNA metabolic process | 7.27% (4/55) | 3.41 | 0.000526 | 0.005654 |
GO:0016070 | RNA metabolic process | 14.55% (8/55) | 2.07 | 0.000563 | 0.005768 |
GO:0006396 | RNA processing | 7.27% (4/55) | 3.3 | 0.000713 | 0.006963 |
GO:0035639 | purine ribonucleoside triphosphate binding | 16.36% (9/55) | 1.85 | 0.000757 | 0.007081 |
GO:0034470 | ncRNA processing | 5.45% (3/55) | 3.92 | 0.000998 | 0.007666 |
GO:0044281 | small molecule metabolic process | 10.91% (6/55) | 2.36 | 0.00105 | 0.007786 |
GO:0017076 | purine nucleotide binding | 16.36% (9/55) | 1.8 | 0.000944 | 0.007802 |
GO:0044237 | cellular metabolic process | 25.45% (14/55) | 1.31 | 0.000995 | 0.007919 |
GO:0032555 | purine ribonucleotide binding | 16.36% (9/55) | 1.81 | 0.000891 | 0.007979 |
GO:0019637 | organophosphate metabolic process | 7.27% (4/55) | 3.19 | 0.000942 | 0.008099 |
GO:0032553 | ribonucleotide binding | 16.36% (9/55) | 1.76 | 0.001182 | 0.008468 |
GO:0097367 | carbohydrate derivative binding | 16.36% (9/55) | 1.73 | 0.001354 | 0.009388 |
GO:0006807 | nitrogen compound metabolic process | 23.64% (13/55) | 1.32 | 0.001542 | 0.010362 |
GO:0090304 | nucleic acid metabolic process | 14.55% (8/55) | 1.79 | 0.001938 | 0.012625 |
GO:0008144 | drug binding | 14.55% (8/55) | 1.75 | 0.002355 | 0.014895 |
GO:0006364 | rRNA processing | 3.64% (2/55) | 4.67 | 0.002691 | 0.01607 |
GO:0016072 | rRNA metabolic process | 3.64% (2/55) | 4.67 | 0.002691 | 0.01607 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 10.91% (6/55) | 2.06 | 0.003026 | 0.017581 |
GO:0090079 | translation regulator activity, nucleic acid binding | 3.64% (2/55) | 4.41 | 0.003882 | 0.01987 |
GO:0045182 | translation regulator activity | 3.64% (2/55) | 4.41 | 0.003882 | 0.01987 |
GO:0008135 | translation factor activity, RNA binding | 3.64% (2/55) | 4.41 | 0.003882 | 0.01987 |
GO:0009451 | RNA modification | 3.64% (2/55) | 4.41 | 0.003882 | 0.01987 |
GO:0008168 | methyltransferase activity | 5.45% (3/55) | 3.28 | 0.003561 | 0.020148 |
GO:0018130 | heterocycle biosynthetic process | 10.91% (6/55) | 1.89 | 0.005338 | 0.020494 |
GO:0030554 | adenyl nucleotide binding | 12.73% (7/55) | 1.7 | 0.005336 | 0.02086 |
GO:0032559 | adenyl ribonucleotide binding | 12.73% (7/55) | 1.71 | 0.005267 | 0.020969 |
GO:0046037 | GMP metabolic process | 1.82% (1/55) | 7.58 | 0.005221 | 0.02118 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 1.82% (1/55) | 7.58 | 0.005221 | 0.02118 |
GO:1901070 | guanosine-containing compound biosynthetic process | 1.82% (1/55) | 7.58 | 0.005221 | 0.02118 |
GO:0003922 | GMP synthase (glutamine-hydrolyzing) activity | 1.82% (1/55) | 7.58 | 0.005221 | 0.02118 |
GO:0006220 | pyrimidine nucleotide metabolic process | 1.82% (1/55) | 7.58 | 0.005221 | 0.02118 |
GO:0006177 | GMP biosynthetic process | 1.82% (1/55) | 7.58 | 0.005221 | 0.02118 |
GO:0004019 | adenylosuccinate synthase activity | 1.82% (1/55) | 7.58 | 0.005221 | 0.02118 |
GO:0003883 | CTP synthase activity | 1.82% (1/55) | 7.58 | 0.005221 | 0.02118 |
GO:0072522 | purine-containing compound biosynthetic process | 3.64% (2/55) | 4.12 | 0.005783 | 0.021812 |
GO:0043168 | anion binding | 18.18% (10/55) | 1.31 | 0.005974 | 0.022145 |
GO:0005524 | ATP binding | 12.73% (7/55) | 1.74 | 0.004546 | 0.022212 |
GO:0019438 | aromatic compound biosynthetic process | 10.91% (6/55) | 1.94 | 0.004482 | 0.022409 |
GO:0006164 | purine nucleotide biosynthetic process | 3.64% (2/55) | 4.26 | 0.004788 | 0.022877 |
GO:1901362 | organic cyclic compound biosynthetic process | 10.91% (6/55) | 1.84 | 0.006309 | 0.02299 |
GO:0036094 | small molecule binding | 18.18% (10/55) | 1.28 | 0.007069 | 0.025332 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:0016597 | amino acid binding | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:0016743 | carboxyl- or carbamoyltransferase activity | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:0009163 | nucleoside biosynthetic process | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:0009123 | nucleoside monophosphate metabolic process | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:0042451 | purine nucleoside biosynthetic process | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:0042455 | ribonucleoside biosynthetic process | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:1901659 | glycosyl compound biosynthetic process | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:1901068 | guanosine-containing compound metabolic process | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:0000428 | DNA-directed RNA polymerase complex | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:0005666 | RNA polymerase III complex | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:0046129 | purine ribonucleoside biosynthetic process | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:0030688 | preribosome, small subunit precursor | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:0006414 | translational elongation | 1.82% (1/55) | 6.58 | 0.010416 | 0.026345 |
GO:0072521 | purine-containing compound metabolic process | 3.64% (2/55) | 3.67 | 0.010603 | 0.026508 |
GO:0071704 | organic substance metabolic process | 25.45% (14/55) | 0.99 | 0.007855 | 0.027687 |
GO:0009058 | biosynthetic process | 14.55% (8/55) | 1.44 | 0.008629 | 0.029923 |
GO:0006163 | purine nucleotide metabolic process | 3.64% (2/55) | 3.77 | 0.009275 | 0.031654 |
GO:1901265 | nucleoside phosphate binding | 16.36% (9/55) | 1.23 | 0.012985 | 0.031724 |
GO:0000166 | nucleotide binding | 16.36% (9/55) | 1.23 | 0.012985 | 0.031724 |
GO:0044249 | cellular biosynthetic process | 12.73% (7/55) | 1.45 | 0.013248 | 0.032004 |
GO:0005737 | cytoplasm | 3.64% (2/55) | 3.49 | 0.013494 | 0.032235 |
GO:0005741 | mitochondrial outer membrane | 1.82% (1/55) | 6.0 | 0.015583 | 0.032847 |
GO:0033588 | Elongator holoenzyme complex | 1.82% (1/55) | 6.0 | 0.015583 | 0.032847 |
GO:0042278 | purine nucleoside metabolic process | 1.82% (1/55) | 6.0 | 0.015583 | 0.032847 |
GO:0043177 | organic acid binding | 1.82% (1/55) | 6.0 | 0.015583 | 0.032847 |
GO:0031406 | carboxylic acid binding | 1.82% (1/55) | 6.0 | 0.015583 | 0.032847 |
GO:0009119 | ribonucleoside metabolic process | 1.82% (1/55) | 6.0 | 0.015583 | 0.032847 |
GO:0031968 | organelle outer membrane | 1.82% (1/55) | 6.0 | 0.015583 | 0.032847 |
GO:0006383 | transcription by RNA polymerase III | 1.82% (1/55) | 6.0 | 0.015583 | 0.032847 |
GO:0003746 | translation elongation factor activity | 1.82% (1/55) | 6.0 | 0.015583 | 0.032847 |
GO:0030880 | RNA polymerase complex | 1.82% (1/55) | 6.0 | 0.015583 | 0.032847 |
GO:0046128 | purine ribonucleoside metabolic process | 1.82% (1/55) | 6.0 | 0.015583 | 0.032847 |
GO:0004749 | ribose phosphate diphosphokinase activity | 1.82% (1/55) | 6.0 | 0.015583 | 0.032847 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 10.91% (6/55) | 1.54 | 0.016284 | 0.033663 |
GO:1901576 | organic substance biosynthetic process | 12.73% (7/55) | 1.39 | 0.016209 | 0.033833 |
GO:0044238 | primary metabolic process | 23.64% (13/55) | 1.0 | 0.010359 | 0.0348 |
GO:0016778 | diphosphotransferase activity | 1.82% (1/55) | 5.58 | 0.020725 | 0.040142 |
GO:0072527 | pyrimidine-containing compound metabolic process | 1.82% (1/55) | 5.58 | 0.020725 | 0.040142 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 1.82% (1/55) | 5.58 | 0.020725 | 0.040142 |
GO:0005852 | eukaryotic translation initiation factor 3 complex | 1.82% (1/55) | 5.58 | 0.020725 | 0.040142 |
GO:0098805 | whole membrane | 1.82% (1/55) | 5.58 | 0.020725 | 0.040142 |
GO:0002098 | tRNA wobble uridine modification | 1.82% (1/55) | 5.58 | 0.020725 | 0.040142 |
GO:0002097 | tRNA wobble base modification | 1.82% (1/55) | 5.58 | 0.020725 | 0.040142 |
GO:0006796 | phosphate-containing compound metabolic process | 7.27% (4/55) | 1.91 | 0.021597 | 0.041092 |
GO:0006793 | phosphorus metabolic process | 7.27% (4/55) | 1.91 | 0.021597 | 0.041092 |
GO:0003674 | molecular_function | 54.55% (30/55) | 0.43 | 0.023054 | 0.04348 |